Findings reference
Find a precise term among 2,612 objective findings.
Findings entries
Choose a page| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
insulin antibody | antibody directed against insulin | The insulin antibody was reported with the treatment history and testing indication. | Objective | Glucose monitoring, endocrine testing and urine studies |
insulin-like growth factor 1 | circulating marker influenced by growth hormone and other factors | Insulin-like growth factor 1 was interpreted against the age-specific reference interval. | Objective | Glucose monitoring, endocrine testing and urine studies |
interstitial glucose lag | delay between blood glucose change and the sensor's interstitial measurement | Interstitial glucose lag was considered during the rapid change after exercise. | Objective | Glucose monitoring, endocrine testing and urine studies |
islet autoantibodies | antibodies against specified pancreatic islet targets | Islet autoantibodies were reviewed individually with the assay results. | Objective | Glucose monitoring, endocrine testing and urine studies |
kappa-to-lambda ratio | ratio of measured kappa and lambda light chains | The kappa-to-lambda ratio was interpreted against the appropriate assay reference. | Objective | Glucose monitoring, endocrine testing and urine studies |
late-night salivary cortisol | saliva cortisol measured at the specified late-night collection time | Late-night salivary cortisol was reviewed with the patient's usual sleep schedule. | Objective | Glucose monitoring, endocrine testing and urine studies |
monoclonal spike | discrete protein peak on electrophoresis consistent with a monoclonal component | Monoclonal spike was quantified in the same units as the prior measurement. | Objective | Glucose monitoring, endocrine testing and urine studies |
morning cortisol | cortisol concentration from a sample collected in the morning | Morning cortisol was documented with the exact clock time and steroid exposure. | Objective | Glucose monitoring, endocrine testing and urine studies |
overnight glucose pattern | repeated glucose behavior between bedtime and waking | The overnight glucose pattern was compared across several recorded nights. | Objective | Glucose monitoring, endocrine testing and urine studies |
parathyroid hormone concentration | measured circulating hormone regulating calcium and phosphate | The parathyroid hormone concentration was assessed with concurrent calcium, phosphate and kidney function. | Objective | Glucose monitoring, endocrine testing and urine studies |
plasma free metanephrines | circulating free catecholamine metabolites used in an endocrine evaluation | Plasma free metanephrines were documented with the collection conditions. | Objective | Glucose monitoring, endocrine testing and urine studies |
plasma renin activity | measure of angiotensin I generation under specified assay conditions | Plasma renin activity was identified separately from a direct renin concentration. | Objective | Glucose monitoring, endocrine testing and urine studies |
polyclonal increase | broad rise in immunoglobulins produced by multiple cell populations | Polyclonal increase was described on the serum protein electrophoresis report. | Objective | Glucose monitoring, endocrine testing and urine studies |
postprandial excursion | change in glucose following a meal | Postprandial excursion was aligned with the recorded meal and dosing times. | Objective | Glucose monitoring, endocrine testing and urine studies |
sensor active time | proportion of a monitoring interval with available sensor data | Sensor active time was reported alongside the glucose summary. | Objective | Glucose monitoring, endocrine testing and urine studies |
sensor compression artifact | apparent sensor low related to pressure at the sensor site | Sensor compression artifact was considered after comparison with a simultaneous fingerstick. | Objective | Glucose monitoring, endocrine testing and urine studies |
sensor glucose | glucose estimate from an interstitial sensor | Sensor glucose was recorded with the displayed trend arrow. | Objective | Glucose monitoring, endocrine testing and urine studies |
serum free light chains | unbound immunoglobulin light chains measured in serum | Serum free light chains were reviewed with the ratio and kidney function. | Objective | Glucose monitoring, endocrine testing and urine studies |
serum osmolality | number of dissolved particles per kilogram of serum water (measured or estimated) | Serum osmolality was reported with the method identified. | Objective | Glucose monitoring, endocrine testing and urine studies |
thyroglobulin antibody | antibody to thyroglobulin that can affect interpretation of some thyroglobulin assays | The thyroglobulin antibody was measured with the thyroglobulin result. | Objective | Glucose monitoring, endocrine testing and urine studies |
thyroglobulin level | concentration of a protein made by thyroid follicular cells | The thyroglobulin level was interpreted with thyroid history and antibody status. | Objective | Glucose monitoring, endocrine testing and urine studies |
thyroid peroxidase antibody | antibody against thyroid peroxidase associated with thyroid autoimmunity | The thyroid peroxidase antibody was documented with the result and assay cutoff. | Objective | Glucose monitoring, endocrine testing and urine studies |
thyroid-stimulating hormone | pituitary signal that regulates thyroid hormone production | Thyroid-stimulating hormone was interpreted with free thyroxine and the medication history. | Objective | Glucose monitoring, endocrine testing and urine studies |
time above range | percentage of sensor time above the stated glucose threshold | Time above range was reported with the threshold used in the download. | Objective | Glucose monitoring, endocrine testing and urine studies |
time below range | percentage of sensor time below the stated glucose threshold | Time below range was reviewed separately for daytime and overnight periods. | Objective | Glucose monitoring, endocrine testing and urine studies |